Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway

ETHNOPHARMACOLOGICAL RELEVANCE: Acute lung injury (ALI) is a common manifestation of COVID-19. Xuanfei Baidu Formula(XFBD) is used in China to treat mild or common damp-toxin obstructive pulmonary syndrome in COVID-19 patients. However, the active ingredients of XFBD have not been extensively studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yanru, Luo, Lifei, Zhang, Meng, Song, Xinbo, Wang, Ping, Zhang, Han, Zhang, Jingze, Liu, Dailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562620/
https://www.ncbi.nlm.nih.gov/pubmed/36252879
http://dx.doi.org/10.1016/j.jep.2022.115833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562620/
https://www.ncbi.nlm.nih.gov/pubmed/36252879
http://dx.doi.org/10.1016/j.jep.2022.115833

Ejemplares similares